← Leaderboards
Tolulope Olatokunbo Akinade
Columbia University Health Sciences
$117,849
Attributed
$117,849
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.8K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$117,849 · 1
By mechanism
F31$117,849 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Ramon E Parsons$25,379,842
- Richard J Baer$14,462,602
- Virginia E. Papaioannou$13,851,118
- Mary Beth Terry$27,685,500
- Beth C Levine$23,805,454
Others in their field
Other Emerging Leaders on “Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$113,883,001
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
DesignDiagnosisAcuteBindingBiocompatible MaterialsBreast Cancer CellAminesBreast Cancer ModelBreast Cancer PatientBreast Cancer ProgressionBreast Cancer TreatmentCancer BiologyCancer DiagnosisCancer SubtypesBreast Cancer MetastasisCell DeathCell Free DnaCellsChargeChemotherapyControl GroupsCytokineDendrimersDna Binding
Grant awards (3)
Design and Application of Cationic Nanocarriers to Inhibit Breast Cancer Progression in Primary and Metastatic Sites$25,061
F31 · FY2023 · CA · contact PI
Design and Application of Cationic Nanocarriers to Inhibit Breast Cancer Progression in Primary and Metastatic Sites$46,752
F31 · FY2022 · CA · contact PI
Design and Application of Cationic Nanocarriers to Inhibit Breast Cancer Progression in Primary and Metastatic Sites$46,036
F31 · FY2021 · CA · contact PI